FACTFILTERHUB

Home›Tag: ApogeeTherapeutics

ApogeeTherapeutics

1 articles tagged

AbbVie logo displayed above laboratory test tubes, illustrating the company's $10.9 billion acquisition of Apogee Therapeutics and expansion into immunology treatments.
Featured

AbbVie's $10.9 Billion Bet on Apogee Could Reshape the Eczema and Asthma Drug Market

AbbVie Apogee acquisition strengthens its immunology pipeline with zumilokibart, a potential rival to Dupixent in eczema and asthma.

Lila•Invalid Date

All Articles

ApogeeTherapeutics News & Articles - AbbVie Apogee acquisition strengthens its immunology pipeline with zumilokibart, a potential rival to Dupixent in eczema and asthma.